REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 36 filers reported holding REPROS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,000 | -37.5% | 3,757 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | +14.3% | 3,757 | -13.1% | 0.00% | – |
| Q2 2016 | $7,000 | +75.0% | 4,324 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -20.0% | 4,324 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -83.9% | 4,324 | +2.8% | 0.00% | – |
| Q3 2015 | $31,000 | +6.9% | 4,208 | +5.2% | 0.00% | – |
| Q2 2015 | $29,000 | -95.2% | 4,001 | -94.4% | 0.00% | -100.0% |
| Q1 2015 | $609,000 | -12.9% | 70,862 | +1.0% | 0.00% | 0.0% |
| Q4 2014 | $699,000 | +3.6% | 70,146 | +2.8% | 0.00% | 0.0% |
| Q3 2014 | $675,000 | -42.3% | 68,211 | +0.9% | 0.00% | -50.0% |
| Q2 2014 | $1,169,000 | +3.5% | 67,576 | +6.1% | 0.00% | 0.0% |
| Q1 2014 | $1,130,000 | -1.7% | 63,692 | +1.4% | 0.00% | 0.0% |
| Q4 2013 | $1,150,000 | -33.0% | 62,838 | -1.9% | 0.00% | -33.3% |
| Q3 2013 | $1,717,000 | +86.4% | 64,069 | +28.3% | 0.00% | +50.0% |
| Q2 2013 | $921,000 | – | 49,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,290,000 | 4.00% |
| SENZAR ASSET MANAGEMENT, LLC | 764,406 | $7,621,000 | 2.23% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $3,280,000 | 0.88% |
| RTW INVESTMENTS, LP | 229,364 | $2,287,000 | 0.85% |
| CQS Cayman LP | 700,000 | $6,979,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $5,068,000 | 0.40% |
| Alden Global Capital Ltd | 154,000 | $1,535,000 | 0.37% |
| J. Goldman & Co LP | 197,500 | $1,969,000 | 0.23% |
| Baker Brothers Advisors | 2,000,000 | $19,940,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $997,000 | 0.17% |